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Varicose veinsAbstract Objective: The aim of this study was to evaluate the role of ultrasound guided foam
sclerotherapy in the treatment of lower limb truncal varicose veins.
Subjects and methods: The study included 30 patients (9 males and 21 females) ranging from 20 to
40 y, with various degrees of varicose veins chosen from the vascular surgery department from April
2013 to April 2014. All patients are evaluated with color Doppler ultrasound system.
Results: The study included nine males (30%) and 21 females (70%) with various degrees of
varicose veins. Each case had foam injection under duplex guidance. All patients suffered from
cosmetic disﬁgurement, whereas 24 patients (80%) complained of leg pain. In the ﬁrst phase (after
2 weeks) 28 patients (93.3%) showed complete clinical improvement of the pre-interventional
symptoms, while only 2 patients (6.7%) showed no improvement. Four patients (13.3%) suffered
from complications in the form of thrombophlebitis. The 2nd phase follow up demonstrated the
ﬁnal patient’s outcomes. 86.7% of the subjected sample (26 patients) showed further improvement.
Conclusion: Foam sclerotherapy is an effective, simple and safe technique for the treatment of
truncal varicose veins with minimal complications.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Varicose veins are elongated, tortuous, and dilated superﬁcial
veins of the lower limbs with deﬁcient valves. The World
Health Organization (WHO) deﬁnes varicose veins as saccular
dilatation of the veins which are often tortuous (1).
They are classiﬁed etiologically into primary and secondary
varicose veins. Secondary varicose veins almost always follow
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obstruction or pump failure or both. The precise cause of pri-
mary varicose veins remains unknown (2).
Sclerotherapy is a minimally invasive technique uses an
injection of a special chemical (sclerosant) into a varicose vein
to damage and scar the inside lining of the vein (3,4).
Foam sclerotherapy is performed under ultrasound control.
The foam solution causes intense spasm of the vein and a
greater volume can be injected without using too much of
the STD solution (5,6).
The initial results with foam sclerotherapy are very promis-
ing and this method of treatment offers a possible alternative
to surgery. Surgery carries a risk of general anesthesia and
the time of work off. Surgery is not more effective than foam
sclerotherapy for primary truncal saphenous vein treatment
(7,8).
The complications of foam sclerotherapy include brown
pigmentation of the skin, deep venous thrombosis (DVT), skin
ulceration, scar and allergic reaction (9,10).2. Aim of the work
The aim of this study is to evaluate the role of ultrasound
guided foam sclerotherapy in the treatment of truncal varicose
veins.
3. Patients and methods
This study was approved by the ethics committee of our insti-
tution during the period between April 2013 and April 2014.
The study group included 30 patients (9 were males and 21
females) ranging from 20 to 40 y with a mean age 30 y, with
various degrees of varicose veins chosen under umbrella of
the study criteria from vascular surgery department. All
patients were evaluated with color Doppler ultrasound system
(Logic 5 Pro, General Electric Medical System, GE
Healthcare, Milwaukee, WI, USA) Ultrasound 5–10 MHz
for the deep and superﬁcial venous system. The exclusion cri-
teria were as follows: Pregnancy, breast feeding, DVT, known
allergy to polidocanol solution (Aethoxysclerol) and lack of
mobility. Inclusion criteria for the study were truncal incompe-
tence in the great saphenous veins as deﬁned by a reﬂux of
more than 0.5 s documented by duplex scan. The chosen
patients underwent ultrasound guided foam sclerotherapy with
early follow up 1–3 days postinjection and long follow up to
6 months. A Tessari micro-foam technique was done using
2 mm Aethoxysclerol 2% to 8 ml sterile air with triple way
cannula. Using sonar guidance the cannula is placed inside
the truncal vein and injection of the foam inside the vein done.
Patients are treated at the operating room in the radiology
department which is equipped with a color duplex ultrasound
and an adjustable examination board.
3.1. Instruction given for patient immediately post procedure
 To walk for at least half hour.
 To have plenty of ﬂuids.
 To maintain external compression for 4 days.
 Given anti-inﬂammatory medication with strict follow
up.3.2. Every patient is advised to
(1) Avoid straining, strenuous physical activity or Valsalva
maneuver for the ﬁrst month because they may contribute to
early recanalization.(2) Avoid prolonged car or plane travel
of more than 4 h during the ﬁrst month after treatment to
decrease the incidence of the thromboembolic events.
4. Results
Thirty patients were selected to fulﬁll the aims and objectives
of this study, nine (30%) males and 21 females (70%), with
various degrees of varicose veins, chosen under umbrella of
study criteria. Each case had single injection with foam under
duplex guidance and the varicosities are assessed after injection
and any complications were observed. Venous reﬂux before
interventional techniques presented in 27 patients (90%) along
the long saphenous vein (Figs. 1B and 2C), 5 patients
(16.7%) had reﬂuxing short saphenous vein. Sixteen patients
(53.3%) had reﬂuxing saphenofemoral junction, whereas 2
patients (6.7%) had reﬂuxing saphenopopliteal junction
(Table 1). All subjected individuals suffered from cosmetic dis-
ﬁgurement, whereas 24 patients (80%) complained of leg pain.
Twenty-one patients (70%) suffered from limb heaviness, and
5 patients (16.7%) complained of itching. The follow up regi-
men was subdivided into two phases: The ﬁrst phase describes
the patient’s manifestation and complications after 2 weeks of
interventional therapy (Figs. 1E and 2A and B), while the
second phase demonstrates the ﬁnal patient’s outcomes after
3 months of interventional therapy. The ﬁrst phase (after
2 weeks) found that 28 patients (93.3%) showed complete clin-
ical improvement of the pre-interventional symptoms
(Table 2), while 2 patients (6.7%) showed no improvement
in his symptoms (Table 3). Four patients (13.3%) suffered
from complications in the form of thrombophlebitis. The
2nd phase follow up demonstrated the ﬁnal patient’s out-
comes. 86.7% of the subjected sample (26 patients) showed
further improvement in the symptoms. Thrombophlebitis,
developed in 2 patients (6.7%) (see Fig. 3).5. Discussion
Sclerotherapy refers to the method of varicose veins interven-
tional treatment, where a chemical substance is introduced into
the lumen of a vein to cause endothelial necrosis and subse-
quent ﬁbrosis. Apart from reducing the size of the vein to a
small ﬁbrous cord, effective sclerotherapy also eliminates the
physiopathological reﬂux associated with varicose veins. It
can be effective for all types of pathological venous dilatations
from major truncal varicose veins to the ﬁnest telangiectases
(11).
Foam sclerotherapy has several advantages from liquid
form; a smaller quantity of sclerosing agent is to be injected,
no dilution with blood and it ensures homogenous effect along
the injected vein, provided the diameter remains reasonable
(11).
A detailed review of the outcomes of ultrasound guided
foam sclerotherapy has been published recently. Cabrera
et al. (12) has published a clinical series of 500 legs treated
by foam sclerotherapy. He reported that after three or more
Fig. 1 A female patient complaining from heaviness of leg pain slightly decreases but preserved with leaning down and wearing an elastic
stock, on regular regimen of venotonics but with no appreciable improvement. (A) Before injection showing multiple dilated tributaries at
the back of the lower thigh. (B) Color Doppler showing reﬂuxing SSV and reﬂuxing tributaries on application of color Doppler. (C)
Demonstrating injection of the tributaries. Needle seen in dilated tributaries. (D) Foam material (white with posterior acoustic shadowing)
in SSV and tributaries after injection. (E) Post injection; sclerotherapy made and the prominent varicose veins literally vanish.
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occluded and 97% of superﬁcial varices had disappeared.
This required one session of sclerotherapy in 86% of patients,
two in 11% and three sessions in 3% of patients. No DVT or
pulmonary embolism was encountered in this series.
Subsequently, a number of authors have published clinical ser-
ies based on this technique including Frullini and Cavezzi (13)
who reported a series of 453 patients, and Barrett et al. (14)
who reported a series of 100 limbs. Cavezzi et al. (15) have sub-
sequently published a detailed analysis of the efﬁcacy of foam
sclerotherapy in 194 patients, reporting a good outcome in
93% of patients. In fact, this technique has become widely
used in southern Europe, Australia, New Zealand, South
America and the USA. The relative efﬁcacy of foam and liquid
sclerotherapy has been investigated in a detailed study. 33
patients with truncal saphenous incompetence were injected
with either 2–2.5 mL of 3% POL liquid or foam into the
GSV under ultrasound guidance, on only one occasion.
Obliteration of saphenous incompetence was obtained in
35% of liquid-treated patients and 85% of foam-treated
patients after three months.
A new treatment for primary varicose veins should be min-
imally invasive and capable of being used on primary and
recurrent varicose veins so that it can be repeated as required.
There should be few signiﬁcant complications and the treat-
ment should have good efﬁcacy in abolishing venous reﬂux
in saphenous trunks, perforating veins and varices (16).
The 1st phase follow up represented 2 weeks after foam
sclerotherapy and the 2nd phase demonstrated ﬁnal patient’s
outcomes after 1.5 months of injection. Jean-Jerome et al.
(17), Arends et al. (18) and Smith (19) also aimed to studythe efﬁcacy and safety of foam sclerotherapy in treating pri-
mary venous insufﬁciency, while Creton and Uhl (20) aimed
to study the short term results of combined peroperative foam
sclerotherapy and surgical treatment for recurrent varicose
veins and Figueredo (21) aimed to compare venous clinical
severity scores in patients with healed venous ulcers due to
varicose veins of the lower limbs treated by saphenous strip-
ping and phlebectomy or by ultrasound-guided foam
sclerotherapy.
In the current study, ultrasound guided foam sclerotherapy
was done by delivering fresh foam (prepared by Tessari
method) into the reﬂuxing veins through cannula while the
patient in supine position, then applying compression tools
post procedure. 1 and 2% concentrations of polidocanol were
used. Jean-Jerome and Arends et al. (17,18) adopted the same
technique. Figueredo (21) adopted the same technique but with
injecting the patient in standing position and then placing him
in Trendelenburg’s position. Smith (19) used 1% polidocanol,
1% sodium tetradecyl and 3% sodium tetradecyl as sclerosing
agents while we used 2% polidocanol in our study. Creton and
Uhl (20) applied the same technique, but using 1% polidocanol.
Regarding the clinical issue, leg pain, heaviness, disﬁgure-
ment, visible varicosities and skin itching were reviewed as
improved or not improved. Firstly, this study achieves high
patient satisfaction with the improvement of the quality of life
and a high rate of closure of the saphenous trunks and visible
varicosities with foam sclerotherapy.
The demographic features of this study included 30
patients, 9 males (30%) and 21 females (70%) with lower limb
varicosities. Age ranged from 620 to P40 years (mean age
32.96 and SD 10.4 years), with 5 patients less than 20 years
Fig. 2 Male patient with GSV incompetence, Color Doppler was done and injection recommended. Injection of GSV done and good
patient satisfaction obtained. (A and B) Pre- and post injection; sclerotherapy made these prominent varicose veins (GSV) literally vanish.
(C) Reﬂuxing GSV seen with duplex examination. (D) Foam seen ﬁling the veins note also the needle itself within the vein. (E) Post
injection 1.5 months showing thrombosed GSV and its caliber is also reduced.
Table 1 Describe pre-interventional patient’s frequency
distribution according to venous reﬂux by Doppler.
Venous reﬂuxing Frequency %
Long saphenous V. 27 90
Short saphenous V. 5 16.7
Giacomine V. 4 13.3
Sapheno-femoral junction 16 53.3
Sapheno-popliteal junction 2 6.7
Table 2 Describe post-interventional improvement upon
radiological basics after the 1st phase.
Patient’s outcomes (radiological success)
(1st phase follow up)
Frequency Percent
(%)
Full V. Obliteration 25 83.3
Partial V. Obliteration with reﬂux 3 10
Partial V. Obliteration without reﬂux 2 6.7
No obliteration 0 0
Total 30 100
984 N.M.M. Osman et al.old (16.7%), 7 patients in the 3rd decade (23.3%), 14 patients
in the 4th decade (46.7%) and 4 patients more than 40 years
old (13.3%). Another study by Creton and Uhl (20) was done
upon 129 patients; 19% of them were males and 81% were
females with average age 55 years, while in Arends et al. (18)
the study was done upon 1252 patients, 55.4% were males
and 64.6% were females with average age 53 years.
By reviewing the Doppler sonographic ﬁndings in pre-
interventional assessment, venous reﬂux was presented in 27
limbs (90%) along the long saphenous vein, 5 limbs (16.7%)along the short saphenous vein. The study conducted by
Arends et al. (18) showed similar results, where 1031 limbs
(82.3%) showed reﬂux in GSV, 248 limbs (19.8%) showed
reﬂux in SSV, 3 limbs (0.2%) showed reﬂuxing Giacomini vein.
In the study conducted by Smith, there were 766 limbs (699%)
with reﬂuxing GSVs alone, 223 limbs (20%) with reﬂuxing
SSVs alone, while there were 120 limbs (11%) with reﬂuxing
both GSV and SSVs. In the study conducted by Creton and
Uhl (20), 100 limbs showed reﬂux in GSV (77.5%) while 29
limbs showed reﬂux in SSV.
Table 3 Describe post-interventional patient’s outcomes
along the 2nd phase of follow up according to the degree of
radiological success.




Full V. Obliteration 24 80
Partial V. Obliteration with reﬂux 2 6.7
Partial V. Obliteration without reﬂux 3 10
No obliteration 1 3.3
Total 30 100
Fig. 3 Describe post-interventional improvement upon radio-
logical basics after the 1st phase.
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this study is in agreement with Vasdekis et al. (22) as 18 cases
(60%) show that the SSV is seen extending up to the thigh
(with high up SPJ), 9 cases (30%) show that SSV joins GSV
at the level of the thigh, 3 cases (10%) show that the SSV is
ended before reaching the pop fossa (end in the calf region).
In the 1st phase follow up (two weeks post injection), most
of the patients (86.9%) showed improvement of symptoms
with minimal complications in the form of thrombophlebitis.
Reassessment of the patients after 3 months revealed that the
majority showed further improvement in the symptoms with
complete absence of the complications, and persistence of
high percentage of radiological and clinical success of the
procedure. Jean-Jerome (17) showed a radiological and clinical
success of about 80% after the ﬁrst session. Arends et al. (18)
showed a success rate of about 84.4% and Ouvry et al. (23)
showed 85% success rate. Our study showed similar results
(86.9% success rate), while Creton and Uhl (20) the success
rate 92%. The differences in success rates between our study
and Creton and Uhl (20) studies were due to Creton and
Uhl (20) underwent multiple sessions of foam sclerotherapy,
while, in the current study, we initially underwent a single
session technique, in addition to the learning curve in this
study. Also these differences may be due to that Creton and
Uhl (20) underwent combined surgical treatment and foam
sclerotherapy, while in this study.
In this study, 2 limbs (6.6%) developed thrombophlebitis,
in agreeing with studies done by Smith (19), where theyreported 5% thrombophlebitis. Thrombophlebitis can be
avoided by occluding the connection of the varicosities with
the truncal veins or the tributaries using various methods of
compression such as applying elastic bandage over the
condyles.
No major systemic complication such as anaphylaxis or
stroke occurred in the current study. No deep venous throm-
bosis occurred and this is in agreement with Arends et al.
(18), while Creton and Uhl (20) (2 reported cases), Smith
(19) (10 reported cases). This may be explained as in our study
we sent the patient immediately after the procedure for ambu-
lation (15 min walking), while in Creton and Uhl study (20),
the patients did not get up and walk immediately post proce-
dure. Also, Creton and Uhl (20) used low concentration poli-
docanol (1%) as a sclerosing agent for injection which
necessitates the injection of higher volumes of polidocanol,
thus promoting the extension of foam bubbles into the deep
system and raising the risk of DVT.
6. Conclusion
Foam sclerotherapy is effective for treatment of truncal vari-
cose veins. 93.3% of the treated patients showed complete clin-
ical improvement of the pre-interventional symptoms
following ﬁrst phase follow up with further improvement after
the 2nd phase follow up. The technique is simple and can be
repeated as required with minimal complications. The tech-
nique should be considered as a new treatment for varicose
veins.
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